Movatterモバイル変換

[0]ホーム
URL:

WO2011109080A3 - A device for intranasal and extranasal neuromodulation - Google Patents

A device for intranasal and extranasal neuromodulationDownload PDF

Info

Publication number
WO2011109080A3
WO2011109080A3PCT/US2011/000379US2011000379WWO2011109080A3WO 2011109080 A3WO2011109080 A3WO 2011109080A3US 2011000379 WUS2011000379 WUS 2011000379WWO 2011109080 A3WO2011109080 A3WO 2011109080A3
Authority
WO
WIPO (PCT)
Prior art keywords
nerve
methods
devices
neuromodulation
stimulation
Prior art date
Application number
PCT/US2011/000379
Other languages
French (fr)
Other versions
WO2011109080A2 (en
Inventor
Michael J. Partsch
Original Assignee
Partsch Michael J
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Partsch Michael JfiledCriticalPartsch Michael J
Publication of WO2011109080A2publicationCriticalpatent/WO2011109080A2/en
Publication of WO2011109080A3publicationCriticalpatent/WO2011109080A3/en

Links

Classifications

Landscapes

Abstract

Systems, devices and methods for treating a subject by neuromodulation of a nerve or nerve cluster accessible from the nasal cavity and/or sinuses. Described herein are systems, devices and methods for treating a patient (or for allowing a patient treat themselves) by stimulation of a nerve, such as the olfactory nerve. In one example, the system, methods and devices are for the treatment of obesity by stimulation of the olfactory nerve to generate a percept such as nausea, satiety, hunger, thirst, pain, discomfort, exhaustion, tiredness, exhilaration, happiness, anxiety, restlessness, calmness, peacefulness, anger, disinterest, satisfaction, aversion, or any combination of the above.
PCT/US2011/0003792010-03-012011-02-28A device for intranasal and extranasal neuromodulationWO2011109080A2 (en)

Applications Claiming Priority (2)

Application NumberPriority DateFiling DateTitle
US30920310P2010-03-012010-03-01
US61/309,2032010-03-01

Publications (2)

Publication NumberPublication Date
WO2011109080A2 WO2011109080A2 (en)2011-09-09
WO2011109080A3true WO2011109080A3 (en)2012-01-19

Family

ID=44542768

Family Applications (1)

Application NumberTitlePriority DateFiling Date
PCT/US2011/000379WO2011109080A2 (en)2010-03-012011-02-28A device for intranasal and extranasal neuromodulation

Country Status (1)

CountryLink
WO (1)WO2011109080A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
WO2013087886A1 (en)*2011-12-162013-06-20Chordate Medical AgDevice for stimulation of hypothalamus
WO2013087885A1 (en)*2011-12-162013-06-20Chordate Medical AgDevice for treatment of headache disorders
US11235146B2 (en)*2014-12-102022-02-01Spr Therapeutics, Inc.Apparatus and method for treating headaches
JP2020089723A (en)2018-12-072020-06-11アヴェント インコーポレイテッドDevice and method for selectively and reversibly modulating nervous system structure to inhibit perception of pain
US12207930B2 (en)2020-12-212025-01-28Xerox CorporationNon-invasive transcranial stimulation system and method using pre-recorded neurostimulation data
US11896852B2 (en)2020-12-212024-02-13Xerox CorporationClosed-loop non-invasive transcranial stimulation and neural activity recording system and method

Citations (5)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US20060047325A1 (en)*2004-07-262006-03-02Mark ThimineurStimulation system and method for treating a neurological disorder
US20060095088A1 (en)*2004-10-212006-05-04Dirk De RidderNew stimulation design for neuromodulation
US20070093870A1 (en)*2005-10-252007-04-26Cyberonics, Inc.Cranial nerve stimulation to treat eating disorders
US7529582B1 (en)*1998-08-052009-05-05Dilorenzo Biomedical, LlcMethod and apparatus for neuromodulation and physiologic modulation for the treatment of metabolic and neuropsychiatric disease
US20100174329A1 (en)*2009-01-022010-07-08Cochlear Limited, IP DepartmentCombined optical and electrical neural stimulation

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US7529582B1 (en)*1998-08-052009-05-05Dilorenzo Biomedical, LlcMethod and apparatus for neuromodulation and physiologic modulation for the treatment of metabolic and neuropsychiatric disease
US20060047325A1 (en)*2004-07-262006-03-02Mark ThimineurStimulation system and method for treating a neurological disorder
US20060095088A1 (en)*2004-10-212006-05-04Dirk De RidderNew stimulation design for neuromodulation
US20070093870A1 (en)*2005-10-252007-04-26Cyberonics, Inc.Cranial nerve stimulation to treat eating disorders
US20100174329A1 (en)*2009-01-022010-07-08Cochlear Limited, IP DepartmentCombined optical and electrical neural stimulation

Also Published As

Publication numberPublication date
WO2011109080A2 (en)2011-09-09

Similar Documents

PublicationPublication DateTitle
WO2011109080A3 (en)A device for intranasal and extranasal neuromodulation
PH12018501330A1 (en)Methods and systems for providing stimuli to the brain
MY188457A (en)Treatment of apolipoprotein-a1 related diseases by inhibition of natural antisense transcript to apolipoprotein-a1
GB201016812D0 (en)Method and apparatus for treating respiratory diesease
MX350378B (en)Enhancement of transport of therapeutic molecules across the blood brain barrier.
WO2013025997A3 (en)Brain stimulation methods for treating central sensitivity
NZ773177A (en)Neuroactive steroid formulations and methods of treating cns disorders
CA2863368A1 (en)Managing back pain by applying a high frequency electrical stimulus directly to the spinal cord
MX2011009752A (en)Treatment of delta-like 1 homolog (dlk1) related diseases by inhibition of natural antisense transcript to dlk1.
WO2010129746A3 (en)Treatment of tristetraproline (ttp) related diseases by inhibition of natural antisense transcript to ttp
BR112012031617A2 (en) incontinence treatment
IN2012DN02325A (en)
GB2512765A (en)Devices and methods for promoting female sexual wellness
WO2011163499A3 (en)Treatment of sodium channel, voltage-gated, alpha subunit (scna) related diseases by inhibition of natural antisense transcript to scna
WO2013138374A3 (en)Treatment of brain derived neurotrophic factor (bdnf) related diseases by inhibition of natural antisense transcript to bdnf
MX2012000034A (en)Methods for treating or preventing fatigue.
BRPI0904955A2 (en) Implantable drug depot to reduce, prevent or treat pain in a patient in need of such treatment and methods for treating acute pain and for making an implantable drug depot.
EP2633052A4 (en)Treatment of interferon-related developmental regulator 1 (ifrd1) related diseases by inhibition of natural antisense transcript to ifrd1
WO2010093904A3 (en)Treatment of brain derived neurotrophic factor (bdnf) related diseases by inhibition of natural antisense transcript to bdnf
MX2009006672A (en)Combined effects of topiramate and ondansetron on alcohol consumption.
WO2010148065A3 (en)Treatment of paraoxonase 1 (pon1) related diseases by inhibition of natural antisense transcript to pon1
WO2012024478A3 (en)Treatment of nicotinamide phosphoribosyltransferase (nampt) related diseases by inhibition of natural antisense transcript to nampt
WO2011143640A3 (en)Treatment of par4 related diseases by inhibition of natural antisense transcript to par4
MX2015012322A (en)Use of levocetirizine and montelukast in the treatment of autoimmune disorders.
WO2011019815A3 (en)Treatment of adiponectin (adipoq) related diseases by inhibition of natural antisense transcript to an adiponectin (adipoq)

Legal Events

DateCodeTitleDescription
NENPNon-entry into the national phase

Ref country code:DE

121Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number:11751016

Country of ref document:EP

Kind code of ref document:A2

122Ep: pct application non-entry in european phase

Ref document number:11751016

Country of ref document:EP

Kind code of ref document:A2
[8]ページ先頭
©2009-2025 Movatter.jp